Exclusive

Publication

Byline

Location

Clinical Trial: Leveraging Optimal Tolerance in Undernourished Infants to Support Growth

U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07549360) titled 'Leveraging Optimal Tolerance in Undernourished Infants to Support Growth' on April 18. Br... Read More


Clinical Trial: Feasibility Study of a Self-Help Psychoeducational Program for Working Adults with ADHD Traits (Japan)

Tokyo, April 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061374) titled 'Feasibility Study of a Self-Help Psychoeducational Program for Working Adu... Read More


Clinical Trial: Pathological complete response and major pathological response as surrogate endpoints in RCTs of neoadjuvant systemic therapies for NSCLC (Japan)

Tokyo, April 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061339) titled 'Pathological complete response and major pathological response as surrogat... Read More


International Clinical Trial: Laser therapy for Pain in individuals with Knee osteoarthrosis

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (RBR-10rr2p5d) titled 'Laser therapy for Pain in individuals with Knee osteoarthrosis' on April 25. S... Read More


International Clinical Trial: Use of virtual nursing rounds at night to prevent falls in hospitalized older patients

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (RBR-5jbrjcb) titled 'Use of virtual nursing rounds at night to prevent falls in hospitalized older pa... Read More


Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, April 24 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More


Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 24 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More


Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, April 24 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 24 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 24 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More